"The breadth and diversity of studies is important because it demonstrates SCRI's ability and commitment to advance therapies for the spectrum of patients with blood cancer." "ASH's selection of 26 abstracts authored by SCRI physician investigators demonstrates the relevance of our clinical research," SCRI Chief Medical Officer Howard A. Burris ... (more)
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20121205005267&newsLang=en&ndmConfigId=1000639&vnsId=41
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20121205005267&newsLang=en&ndmConfigId=1000639&vnsId=41
No comments:
Post a Comment